pocketful logo
J B Chemicals & Pharmaceuticals Ltd logo

J B Chemicals & Pharmaceuticals Ltd

NSE: JBCHEPHARM BSE: 506943

2149.80

(0.31%)

Tue, 19 May 2026, 04:03 am

J B Chemicals & Pharmaceuticals Share Price Live Chart

1 Day

(0.31%)

No Result Found

Summary

  • Market Cap

    34116.32

  • Net Profit

    659.58

  • P/B

    7.36

  • Sector P/E

    35.36

  • P/E

    38.29

  • EV/EBITDA

    23.50

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    14.05

  • RONW (Industry)

    13.18

  • ROE

    20.75

  • ROCE

    26.42

  • Debt/Equity

    0.06

  • EPS (TTM)

    45.45

  • Dividend Yield

    0.44

  • Book Value

    259.05

  • Interest Cover

    76.65

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are well covered by earnings (6.7x coverage).
  • Dividends after 3 years are expected to be well covered by earnings (5.8x coverage).
  • J. B. Chemicals & Pharmaceuticals's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • J. B. Chemicals & Pharmaceuticals's earnings growth is expected to exceed the low risk savings rate of 7.2%.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • J. B. Chemicals & Pharmaceuticals's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • Cash flow for J. B. Chemicals & Pharmaceuticals is expected to increase but not above the 50% threshold in 2 years time.
  • J. B. Chemicals & Pharmaceuticals's earnings are expected to grow by 12.8% yearly, however this is not considered high growth (20% yearly).
  • J. B. Chemicals & Pharmaceuticals's earnings growth is positive but not above the India market average.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters48.8047.5547.5647.7347.84
FII16.3314.8815.3017.7718.31
DII21.3823.3622.8319.6318.72
Public13.4814.2214.3014.8815.13
Government0.000.00000

Read More

Technical Analysis

RSI

59.44

MACD

32.25

50 DMA

2063.52

200 DMA

1856.20

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic2433.802223.402133.40201319231802.601592.20
Fibonacci2223.402143.032093.3720131932.631882.971802.60
Camarilla2101.262081.972062.6920132024.112004.831985.54

Pivots Level: Classic

R3

+420.80

2433.80

R2

+210.40

2223.40

R1

+120.40

2133.40

2013
2013
Pivot Point
LTP: 2150.60

S1

-90

1923

S2

-210.40

1802.60

S3

-420.80

1592.20

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    2127.32

  • 20-EMA

    2101.08

  • 30-EMA

    2082.76

  • 50-EMA

    2053.98

  • 100-EMA

    1989.16

  • 200-EMA

    1901.83

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
11 May 2026board-meetingsAccounts, Final Dividend
27 Mar 2026egm
05 Feb 2026dividend₹12.70 Dividend /Share11 Feb 2026
16 Jan 2026board-meetingsQuarterly Results
11 Jan 2026dividendInterim Dividend - Rs. - 12.711 Feb 2026
11 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
11 Jul 2025agm
30 Jun 2025dividendFinal Dividend - Rs. - 730 Jul 2025
14 May 2025dividend₹7.00 Dividend /Share30 Jul 2025
04 Feb 2025dividend₹8.50 Dividend /Share08 Feb 2025

Read More

Peer Comparison

J B Chemicals & Pharmaceuticals Ltd logo

J B Chemicals & Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

J B Chemicals & Pharmaceuticals Ltd About

J B Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs).

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1976

Headquarters

CEO

Arun Duggal

Employees

Contact

Website icon

Website

http://www.jbpharma.com

Email icon

Email

investorelations@jbpharma.com; secretarial@jbpharm

Phone icon

Phone

91-022-2482 2222/2493 0918

Location icon

Location

Neelam Centre 4th Floor, B-Wing Hind Cycle Road Worli, Mumbai, Maharashtra, 400030

Read More

J B Chemicals & Pharmaceuticals Ltd Company History

YearHistory
No Result Found

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
TAU INVESTMENT HOLDINGS PTE LIMITEDbulkSell22457861625.0127 Mar 2025
KOTAK MAHINDRA MUTUAL FUNDbulkBuy1230769162527 Mar 2025
TAU INVESTMENT HOLDINGS PTE LIMITEDbulkSell22457861625.3427 Mar 2025
TAU INVESTMENT HOLDINGS PTE LIMITEDbulkSell2245787162527 Mar 2025
TAU INVESTMENT HOLDINGS PTE LIMITEDbulkSell2245786162527 Mar 2025
SOCIETE GENERALEblockBuy1042411693.825 Jan 2024
BNP PARIBAS ARBITRAGEblockSell1042411693.825 Jan 2024
THE VANGUARD GROUP INC A/C VANGUARD EMERG. MKTS STOCK INDEXFD A SERIES OF V I E I FbulkBuy7067561121.8918 Sept 2020
ASHISH DHAWANbulkSell472096289.5402 Nov 2017
ASHISH DHAWANbulkSell1952206288.1201 Nov 2017

Read More

J B Chemicals & Pharmaceuticals Ltd News

JB Pharma Q4 FY26: Revenue Rs. 904 Cr, PAT Down 30%

JB Pharma Q4 FY26 revenue fell 5% YoY to INR 904 cr; reported PAT down 30% to INR 101 cr. Adjusted PAT at INR 150 cr. Torrent merger hearing set for second week of June.

14 May 2026

companies

JB Pharma Q4 FY26 Earnings Call: Key Highlights

JB Pharma Q4 FY26 call covered operational reset post Torrent acquisition, revenue of INR904 cr (-5% YoY), PAT INR101 cr (-30% YoY), segment updates, merger timeline, and synergy strategy.

13 May 2026

companies

J.B. Chemicals Sees ₹24.13 Cr NSE Block Trade

J.B. Chemicals & Pharmaceuticals recorded a block trade on NSE worth ₹24.13 crores, involving approximately 114,640 shares at a price of ₹2105.00 per share.

13 May 2026

equity-markets

JB Pharma-Torrent Pharma Merger Hearing Set for June 11

J.B. Chemicals & Pharmaceuticals has disclosed a Notice of Hearing of Petition for its Scheme of Amalgamation with Torrent Pharmaceuticals, with the NCLT Ahmedabad Bench hearing scheduled for June 11, 2026.

13 May 2026

companies

JB Pharma Q4 FY26: Revenue Rs. 904 Cr, PAT Down 30% YoY

JB Chemicals & Pharmaceuticals reported Q4 FY26 revenue of Rs. 904 crores (-5% YoY) and PAT of Rs. 101 crores (-30% YoY). FY26 full-year revenue grew 6% to Rs. 4,148 crores; PAT up 8% to Rs. 709 crores.

13 May 2026

companies

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800